Image
30.11.2022
WE’RE CALLING FOR NEW RESEARCH INTO SIGHT LOSS
We’ve partnered with Fight for Sight, the Macular Society and Moorfields Eye Charity, to co-fund new rese...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more